Quick Summary
Click here for Price and Turnaround Time
Phenotype: Signs of centronuclear myopathy include generalized loss of muscle tone and control, exercise intolerance, and an awkward gait. CNM typically manifests in puppies at 2-5 months of age.
Mode of Inheritance: Autosomal recessive
Alleles: N = Normal, CNM = Centronuclear myopathy
Breeds appropriate for testing: Labrador Retriever
Explanation of Results:
- Dogs with N/N genotype will not have centronuclear myopathy and cannot transmit this CNM variant to their offspring.
- Dogs with N/CNM genotype will not be affected by centronuclear myopathy, but are carriers. They will transmit this CNM variant to 50% of their offspring. Matings between two carriers are predicted to produce 25% centronuclear myopathy-affected puppies.
- Dogs with CNM/CNM genotype will have centronuclear myopathy.
Results of this test can be submitted to the OFA (Orthopedic Foundation for Animals)
Labrador Retriever Health Panel 1
$165 per animal
Labrador Retriever Health Panel 2
$180 per animal
Centronuclear myopathy (CNM) is a hereditary myopathy of Labrador Retrievers resulting from a mutation in the protein tyrosine phosphatase-like member A gene (PTPLA). PTPLA codes for a dehydratase enzyme that functions in the production of long chain fatty acids, these molecules are thought to be involved in muscle homeostasis. While the precise role of PTPLA in this disease is unknown, the CNM mutation has been shown to lead to a reduction in normal gene product.
The disease is inherited in an autosomal recessive fashion with both sexes equally affected.
This condition has also been called type II muscle fiber deficiency, autosomal recessive muscular dystrophy, and hereditary myopathy.
CNM typically manifests in puppies at age 2-5 months. Signs of CNM include generalized loss of muscle tone and control, exercise intolerance, and an awkward gait. Dogs with one normal copy and one mutant copy of the gene (heterozygous) do not display signs. Breeding two carriers is predicted to produce 25% affected offspring and 50% carriers of the disease.
Testing for CNM can assist clinicians, owners, and breeders in identifying affected and carrier dogs. Breeders can use results from the test as a tool for selection of mating pairs to avoid producing affected dogs.
